Skip to main content
PRME logo
PRME
(NASDAQ)
Prime Medicine, Inc.
$3.32-- (--)
Loading... - Market loading

Prime Medicine (PRME) Stock Price & Financial Analysis

Prime Medicine Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.23 - $3.45
52-Week High$6.94
52-Week Low$1.11
Open$3.23
Volume1.65M
Average Volume (3M)1.65M
Market Cap493.88M
Shares Outstanding148.76M
Price to Sales (P/S)108.87
Price to Book (P/B)4.17
EV/EBITDA-2.80
Revenue (TTM)4.63M
Net Income (TTM)-201.14M
Free Cash Flow (TTM)-167.09M
EPS (TTM)$-1.35
Profit Margin-4342.44%
Operating Margin-4498.06%
Return on Equity (ROE)-166.41%
Debt to Equity0.96
50-Day MA$3.76
200-Day MA$4.01
52-Week Change89.92%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Prime Medicine

What is the current stock price for PRME?

As of the latest trading session, PRME stock trades at $3.32. The 52-week range is $1.11–$6.94, with a day range of $3.23–$3.45.

What is the P/E ratio for PRME?

The P/E ratio (Price-to-Earnings) for PRME is shown in the Key Statistics section. This valuation metric helps compare Prime Medicine, Inc. to industry peers.

Does PRME pay dividends?

Prime Medicine does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PRME?

Based on 1 analyst, the consensus for PRME is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of PRME?

Prime Medicine's market capitalization is $493.9M, classifying it as a small-cap company. Prime Medicine operates in the Healthcare sector within the Biotechnology industry.